CardioComm Solutions Announces Release of GEMSTM Windows 7 Compatible, Remote Patient Monitoring Technology
28 Marzo 2014 - 7:57AM
Access Wire
CardioComm Solutions to begin
immediate rollout of GEMSTM for Windows
7 remote ECG analysis, data management software to extensive base
of current US health care providers and customers.
TORONTO, ONTARIO / ACCESSWIRE / March 28, 2014 /
CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm
Solutions" or the "Company"), a global medical provider of
electrocardiogram ("ECG") acquisition and data management software
solutions, is pleased to announce it will launch its new Global ECG
Management System release (GEMSTM WIN), a Windows 7 compatible
version of the Company's GEMSTM software technology in June
2014.
The Company's GEMSTM software is
an industry standard clinic and service provider based software
system used for remote ECG acquisition, analysis and data
management for cardiac arrhythmia monitoring and implantable device
follow up of patients by health care providers and services across
the globe. Remote patient monitoring and follow up is a critical
operational component of every cardiology practice internationally
and gaining rapid adoption across the entire health care
landscape.
CardioComm Solutions' release of
GEMSTM WIN is in response to the
anticipated end of Microsoft support for Windows XP in April of
2014. The GEMSTM WIN software release
will allow for functional operation of GEMSTM
on the Windows 7 Operating System. Direct communications with
existing GEMSTM customers and scheduling
of GEMSTM WIN installations will begin in
April. The Company confirms that GEMSTM
WIN has been designed to maintain the exact functionality
with familiar navigation and customizations that CardioComm
Solutions customers previously had with their existing
GEMSTM systems on the Windows XP
Operating System.
"Moving to the new GEMSTM WIN
release will ensure minimum downtime associated with the typical
need for staff re-training, education and/ or application
redevelopment of customer preferred reporting and operational
capabilities. The aggressive marketing and promotions planned for
the release of GEMSTM WIN for the Windows
7 OS compatible platform is anticipated to generate immediate sales
revenue, market share growth and positive operating results for
2014," said Simi Grosman, member of the Company's board of
directors.
"We are very pleased to offer our new, Windows 7
compatible version of GEMSTM to our
existing customers," commented Etienne Grima, CEO of CardioComm
Solutions. "The GEMSTM WIN system will
provide remote patient monitoring of cardiac arrhythmia and
implantable device patients every day through health care providers
and cardiac monitoring services. We will continue to enhance the
GEMSTM technology platform to meet the
current and future needs of the health care community as technology
advances. This Windows 7 based release paves the way for the
exciting introductions of future releases of our ECG interpretation
and management technologies and service solutions in the coming
year."
"Our GEMSTM for Windows 7
release is a welcomed and exciting development that will solidify
our technology provider relationship with hundreds of
cardiology-based clinical providers and monitoring services across
the United States and internationally," commented Dan Pawlik, Vice
President of Sales and Marketing for CardioComm Solutions. "For
those customers who wish to continue operations with the existing
features and benefits of the GEMSTM-3 XP
platform, this upgrade provides a nearly seamless transition. For
new customers, we can now provide the benefits of
GEMSTM and our future system
enhancements without eminent Operating System
obsolesce."
About CardioComm Solutions
CardioComm Solutions' patented and proprietary technology is
used in products for recording, viewing, analyzing and storing
electrocardiograms (ECGs) for diagnosis and management of cardiac
patients. Products are sold worldwide through a combination of an
external distribution network and a North American-based sales
team. The Company has earned the ISO 13485 certification, is HPB
approved, HIPAA compliant, and has received FDA market clearance
for its software devices. CardioComm Solutions is headquartered in
Toronto, Ontario, Canada, with offices in Victoria, B.C.
FOR FURTHER INFORMATION PLEASE CONTACT:
Etienne Grima, Chief Executive Officer
1-877-977-9425
investorrelations@cardiocommsolutions.com
www.cardiocommsolutions.com
Forward-looking statements
This release may contain certain forward-looking
statements and forward looking information with respect to the
financial condition, results of operations and business of
CardioComm Solutions and certain of the plans and objectives of
CardioComm Solutions with respect to these items. Such
statements and information reflect management's current beliefs and
are based on information currently available to management.
By their nature, forward-looking statements and
forward-looking information involve risk and uncertainty because
they relate to events and depend on circumstances that will occur
in the future and there are many factors that could cause actual
results and developments to differ materially from those expressed
or implied by these forward-looking statements and forward-looking
information.
In evaluating these statements, readers should:
specifically consider risks discussed under the heading
"Risk Factors" in the Company's Annual
Information Form, available at
www.sedar.com; not to place undue reliance on
forward-looking statements and forward-looking information; be
aware the Company does not assume any obligation to update the
forward-looking statements and forward-looking information
contained in this Annual Information Form other than as required by
applicable laws (including without limitation Section 5.8(2) of
National Instrument 51-102 (Continuous Disclosure
Obligations).
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
SOURCE: CardioComm Solutions, Inc.
CardioComm Solutions (TSXV:EKG)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
CardioComm Solutions (TSXV:EKG)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024